These are exposure studies associated with the disease and all of its children.
|Reference||Associated Study Title||Author's Summary||Study Factors||Stressor||Receptors||Country||Medium||Exposure Marker||Measurements||Outcome|
|1.||Lyall K, et al. (2017).||Early Markers for Autism (EMA) | Project Baby's Breath (PBB)||The overall pattern of our results suggests increases in risk of autism spectrum disorder and intellectual disability without autism with prenatal exposure to higher levels of a number of organochlorine compounds, particularly polychlorinated biphenyl ethers.||2,2',3,3',4,4',5-
||Controls for disease:Autism Spectrum Disorder | Subjects with disease:Autism Spectrum Disorder | Children | Controls for disease:Intellectual Disability | Subjects with disease:Intellectual Disability | Pregnant females||United States||serum||2,2',3,3',4,4',5-
||Details||Autism Spectrum Disorder | Intellectual Disability | Prenatal Exposure Delayed Effects|
|2.||Herbstman JB, et al. (2010).||This epidemiologic study demonstrates neurodevelopmental effects in relation to cord blood polybrominated diphenyl ether concentrations.||2,2',4,4',5,6'-
||Infants or newborns||United States||blood, cord||2,2',3,4,4',5',6-
||Details||Intellectual Disability | Psychomotor Disorders | cognition|